A non ouabain-like inhibitor of the sodium pump in uremic plasma ultrafiltrates and urine from healthy subjects

Clinica Chimica Acta

Volumn 273, Issue 2, 1998, Pages 149-160

  Gallice, Philippe M ^a   Kovacic, Hervé N ^a   Brunet, Philippe J ^b   Berland, Yvon F ^b   Crevat, Aimé D ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Ouabain; Sodium pump inhibitor; Uremia

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ENZYME INHIBITOR; MAGNESIUM; OUABAIN; SODIUM DIHYDROGEN PHOSPHATE; VANADIUM;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; ENZYME ASSAY; ENZYME KINETICS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; ULTRAFILTRATION; UREMIA; URINALYSIS;

ADENOSINE TRIPHOSPHATE; ENZYME INHIBITORS; HEMOFILTRATION; HUMANS; KINETICS; NA(+)-K(+)-EXCHANGING ATPASE; OUABAIN; POTASSIUM; REFERENCE VALUES; UREMIA;

STROPHANTHUS GRATUS;

EID: 0032565680     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00032-1     Document Type: Article

References (20)

1. [1] Welt LG, Sachs JR, McManus TJ. An ion transport defect in erythrocytes from uremic patients. Trans Assoc Am Phys 1964;77:169-81.
2. + pump in chronic renal failure. Am J Physiol 1987;252:F785-93.
3. [3] Sohn HJ, Stokes GS, Johnston H. An Na,K ATPase inhibitor from ultrafiltrate obtained by hemodialysis of patients with uremia. J Lab Clin Med 1992;120:264-71.
4. [4] Cheng JT, Kahn T, Kaji DM. Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure. J Clin Invest 1984;74:1811-20.
5. [5] Doris PA. Endogenous inhibitors of the Na-K pump. Miner Electrolyte Metal 1996;22:303-10.
6. + pump inhibition by a fraction from uremic toxins. Clin Chem 1988;34:2044-7.
7. [7] Gallice P, Sabatier M, Kovacic H, Brunet P, Berland Y, Crevat A. An affinity procedure for primary isolation of a non ouabain toxin inhibiting the Na,K-ATPase (Abstract). In: 33th Congress of European Dialysis and Transplant Association. Amsterdam, 1996, Abstract book, p. 180.
8. [8] Rose AM, Valdes Jr. R. Understanding the sodium pump and its relevance to disease. Clin Chem 1994;40:1674-85.
9. [9] Hurst RO. The determination of nucleotide phosphorus with a stannous chloride-hydrazine sulfate reagent. Can J Biochem 1964;42:287-92.
10. [10] Ludens JH, Clark MA, Du Charme DW et al. Purification of an endogenous digitalislike factor from human plasma for structural analysis. Hypertension 1991;17:923-9.
11. [11] Hamlyn JM, Manunta P. Ouabain, digitalin-like factor and hypertension. J Hypertens 1992;10(suppl 7):S99-S111.
12. [12] Mathews WR, Du Charme DW, Hamlyn JM et al. Mass spectral characterization of an endogenous digitalislike factor from human plasma. Hypertension 1991;17:930-5.
13. [13] Van Winkle WB, Allen JC, Schwartz A. Nature of the transport ATPase-digitalis complex: III. Rapid binding studies and effects of ligands on the formation and stability of magnesium plus phosphate-induced glycoside-enzyme complex. Arch Biochem Biophys 1972;151:85-92.
14. [14] Bonting SL. Sodium-potassium activated adenosine transport. In: Bittar EE, editor. Membrane ion transport. Wiley Interscience 1970:257-363.
15. +-dependent adenosine triphsophate from cardia tissue. Biochem Biophys Res Co 1966;25:147-52.
16. [16] Cantley LC, Josephson L. A slow interconversion between active and inactive states of the NaK-ATPase. Biochemistry 1976;15:5280-7.
17. [17] Rossier BC, Geering K, Kraehenbuhl JP. Regulation of the sodium pump: how and why? Trends Biochem Sci 1987;12:483-7.
18. [18] Gallice P, Lai E, Brunet P, Berland Y, Elsen R, Crevat A. In vivo accumulation of sodium pump inhibitor by normal and uremic erythrocytes. J Artif Organs 1993;16(3):120-2.
19. [19] Kramer HJ, Krampitz G, Bäcker A, Krampitz Jr. G, Meyer-Lehnert H. Vanadium-diascorbates are strong candidates for endogenous ouabain-like factors in human urine: Effects on NaK-ATPase enzyme kinetics. Biochem Biophys Res Co 1995;213(1):289-94.
20. [20] Kelly RA, O'Hara DS, Mitch WE, Smith TW. Identification of NaK-ATPase-inhibitors in human plasma as nonesterified fatty acids and lysophospholipids. J Biol Chem 1986;261(25):11704-11.